Amarin Corp Adr (AMRN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Amarin Corp Adr Stock (AMRN) Company Profile

Amarin Corp Adr

Healthcare (1111)

353 1 6699 020

SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2

Prossima data di guadagno

Ultimi documenti SEC

AMRN's Discussions on Twitter

Compare AMRN vs LLY, JNJ, ABBV, AZN, NVS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AMRN Amarin Corp Adr	14.74	308.98M	306.91M	-59.11M	6.35M	-0.15
LLY Lilly Eli Co	1,040.00	929.27B	65.18B	20.64B	6.44B	22.96
JNJ Johnson Johnson	243.45	589.19B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	231.50	402.08B	61.16B	4.20B	19.68B	2.3671
AZN Astrazeneca Plc	205.55	317.06B	58.80B	10.24B	8.98B	3.2788
NVS Novartis Ag Adr	163.10	307.56B	54.72B	14.02B	15.32B	7.1855

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-11-20	Ripresa	JP Morgan	Underweight
2023-10-25	Downgrade	Jefferies	Buy → Hold
2023-01-06	Aggiornamento	Jefferies	Hold → Buy
2022-05-06	Downgrade	JP Morgan	Neutral → Underweight
2022-05-05	Downgrade	H.C. Wainwright	Buy → Neutral
2022-05-05	Downgrade	SVB Leerink	Outperform → Mkt Perform
2022-05-04	Downgrade	Northland Capital	Outperform → Market Perform
2021-05-12	Downgrade	Goldman	Neutral → Sell
2020-09-29	Ripresa	JP Morgan	Neutral
2020-08-26	Iniziato	Piper Sandler	Overweight
2020-05-05	Iniziato	Northland Capital	Outperform
2020-03-31	Downgrade	Goldman	Buy → Neutral
2020-03-31	Downgrade	Jefferies	Buy → Hold
2020-03-31	Aggiornamento	Oppenheimer	Underperform → Perform
2020-03-13	Aggiornamento	Goldman	Neutral → Buy
2020-03-02	Iniziato	Cowen	Outperform
2020-02-18	Aggiornamento	Citigroup	Neutral → Buy
2020-01-06	Iniziato	JP Morgan	Neutral
2019-12-16	Downgrade	Stifel	Buy → Hold
2019-11-20	Iniziato	Oppenheimer	Underperform
2019-11-18	Downgrade	Citigroup	Buy → Neutral
2019-11-15	Reiterato	SVB Leerink	Outperform
2019-10-31	Iniziato	Aegis Capital	Buy
2019-10-15	Iniziato	Goldman	Neutral
2019-08-14	Iniziato	SVB Leerink	Outperform
2019-07-09	Reiterato	Jefferies	Buy
2019-06-17	Iniziato	ROTH Capital	Buy
2019-03-22	Iniziato	Stifel	Buy

Mostra tutto

Amarin Corp Adr Borsa (AMRN) Ultime notizie

Amarin Corp Adr Azioni (AMRN) Dati Finanziari

Amarin Corp Adr (AMRN)

Amarin Corp Adr Stock (AMRN) Company Profile

Compare AMRN vs LLY, JNJ, ABBV, AZN, NVS

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Amarin Corp Adr Borsa (AMRN) Ultime notizie

BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? - Yahoo Finance

Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights - Finviz

AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations - Finviz

China Universal Asset Management Co. Ltd. Sells 76,302 Shares of Amarin Corporation PLC $AMRN - Defense World

Net current asset value per share of Amarin Corporation Plc Sponsored ADR – MUN:EH3 - TradingView — Track All Markets

Companies Like Amarin (NASDAQ:AMRN) Are In A Position To Invest In Growth - Sahm

Tops & Flops Stocks - sharewise.com

RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION - GlobeNewswire Inc.

Amarin (AMRN) Unprofitable as Losses Worsen, Profit Growth Forecasts Test Bullish Turnaround Hopes - Sahm

Leerink Partners raises Amarin stock price target to $12 on strong Q3 - Investing.com

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program - ADVFN

Cash from operating activities of Amarin Corporation Plc Sponsored ADR – SWB:EH3 - TradingView

Amarin Corporation plc (NASDAQ:AMRN) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - Sahm

Amarin Corporation plc Announces $17.8 Million Registered Direct Offering of American Depositary Shares - ADVFN

Amarin stock rises after ESC Congress data on VASCEPA mechanism - Investing.com

Earnings call transcript: Amarin Q2 2025 sees revenue beat, stock stable - Investing.com

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Yahoo Finance

Amarin Gears Up To Report Q2 Earnings: Here's What To Expect - Barchart.com

3 Strong Buy Breakout Stocks for Explosive Returns - The Globe and Mail

FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill - Finviz

PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study - Finviz

Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU - Yahoo Finance

Amarin stock jumps after $25 million licensing deal with Recordati - Investing.com

Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma - Finviz

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

KURA Stock Rises More Than 15% This Past Week: Here's Why - The Globe and Mail

SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease - Finviz

Kymera Stock Gains on Positive Data on Investigational Dermatitis Drug - Finviz

Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year? - Yahoo Finance

VSTM Stock Soars 22% in a Month on Ovarian Cancer Combo Drug Approval - Finviz

Amarin Corp PLC Share Price ADR Each Rep 20 Ord Spon - Hargreaves Lansdown

Amarin announces ADS ratio change to meet Nasdaq requirements - Investing.com

Amarin adds investment expert Michael Torok to Board By Investing.com - Investing.com

Amarin urged to review strategy by major shareholders - Investing.com

The Market Doesn't Like What It Sees From Amarin Corporation plc's (NASDAQ:AMRN) Revenues Yet As Shares Tumble 26% - Sahm

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance

Amarin Plans Major ADR Restructuring: What This 1:20 Ratio Change Means for Investors - Stock Titan

Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative

Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Investing.com UK

Free float of Amarin Corporation Plc Sponsored ADR – NASDAQ:AMRN - TradingView

symbol__ Stock Quote Price and Forecast - CNN

Sarissa Capital Calls for Amarin Special Meeting to Vote on Its Nominees - 24/7 Wall St.

Amarin CorpADR (AMRN) News, Articles, Events & Latest Updates - Stocktwits

Validea Kenneth Fisher Strategy Daily Upgrade Report9/24/2022 - Nasdaq

AMRN Forecast — Price Target — Prediction for 2026 - TradingView

HLS Announces that Vascepa® is now reimbursed by Ontario's Provincial Drug Plan - The Globe and Mail

Generic-Drug Labeling Strategy Likely to Survive Teva Rehearing - Bloomberg.com

The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs - Yahoo Finance

Amarin Stock Melts Down After Losing Patent Battle For Heart Drug - Investor's Business Daily

Amarin stock heads toward highest prices in more than a decade after new Vascepa FDA approval - MarketWatch

This Biotech Stock Just Got A Highly Anticipated FDA Approval - Investor's Business Daily

Amarin Corp Adr Azioni (AMRN) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a AMRN